BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 12504935)

  • 1. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
    Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
    BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
    Spencer K; Cowans NJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
    Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T
    Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First trimester levels of inhibins and activin A in normal and failing pregnancies.
    Wallace EM; Marjono B; Tyzack K; Tong S
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):484-90. PubMed ID: 15049964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia.
    Aquilina J; Maplethorpe R; Ellis P; Harrington K
    Placenta; 2000; 21(5-6):487-92. PubMed ID: 10940198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
    Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
    Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
    Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
    Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia.
    Hamar BD; Buhimschi IA; Sfakianaki AK; Pettker CM; Magloire LK; Funai EF; Copel JA; Buhimschi CS
    Am J Obstet Gynecol; 2006 Dec; 195(6):1636-45. PubMed ID: 16959203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
    Wald NJ; Morris JK; Ibison J; Wu T; George LM
    Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of preeclampsia using inhibin a and other second-trimester serum markers.
    Ree PH; Hahn WB; Chang SW; Jung SH; Kang JH; Cha DH; Kang MS; Huh JY
    Fetal Diagn Ther; 2011; 29(4):280-6. PubMed ID: 21252475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of pre-eclampsia.
    Luckas M; Hawe J; Meekins J; Neilson J; Walkinshaw S
    Acta Obstet Gynecol Scand; 1998 Apr; 77(4):381-4. PubMed ID: 9598944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.
    Florio P; Ciarmela P; Luisi S; Palumbo MA; Lambert-Messerlian G; Severi FM; Petraglia F
    Gynecol Endocrinol; 2002 Oct; 16(5):365-72. PubMed ID: 12587530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
    Yu J; Shixia CZ; Wu Y; Duan T
    Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels.
    Räty R; Koskinen P; Alanen A; Irjala K; Matinlauri I; Ekblad U
    Prenat Diagn; 1999 Feb; 19(2):122-7. PubMed ID: 10215068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second trimester serum markers.
    Canick JA; MacRae AR
    Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum activin A levels in association with intrauterine fetal growth restriction.
    Wallace EM; Schneider-Kolsky ME; Edwards A; Baker L; Jenkin G
    BJOG; 2003 Mar; 110(3):306-10. PubMed ID: 12628273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage.
    Prakash A; Laird S; Tuckerman E; Li TC; Ledger WL
    Fertil Steril; 2005 Jun; 83(6):1758-63. PubMed ID: 15950648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity.
    Kang JH; Farina A; Park JH; Kim SH; Kim JY; Rizzo N; Elmakky A; Jun HS; Hahn WB; Cha DH
    Prenat Diagn; 2008 Aug; 28(8):704-9. PubMed ID: 18655226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quad screen as a predictor of adverse pregnancy outcome.
    Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.